276 related articles for article (PubMed ID: 31160716)
41. Broad tumor spectrum in a mouse model of multiple endocrine neoplasia type 1.
Loffler KA; Biondi CA; Gartside M; Waring P; Stark M; Serewko-Auret MM; Muller HK; Hayward NK; Kay GF
Int J Cancer; 2007 Jan; 120(2):259-67. PubMed ID: 17044021
[TBL] [Abstract][Full Text] [Related]
42. Pasireotide Therapy of Multiple Endocrine Neoplasia Type 1-Associated Neuroendocrine Tumors in Female Mice Deleted for an Men1 Allele Improves Survival and Reduces Tumor Progression.
Walls GV; Stevenson M; Soukup BS; Lines KE; Grossman AB; Schmid HA; Thakker RV
Endocrinology; 2016 May; 157(5):1789-98. PubMed ID: 26990064
[TBL] [Abstract][Full Text] [Related]
43. Altered MENIN expression disrupts the MAFA differentiation pathway in insulinoma.
Hamze Z; Vercherat C; Bernigaud-Lacheretz A; Bazzi W; Bonnavion R; Lu J; Calender A; Pouponnot C; Bertolino P; Roche C; Stein R; Scoazec JY; Zhang CX; Cordier-Bussat M
Endocr Relat Cancer; 2013 Dec; 20(6):833-48. PubMed ID: 24157940
[TBL] [Abstract][Full Text] [Related]
44. Loss of Menin Expression by Immunohistochemistry in Pancreatic Neuroendocrine Tumors: Comparison Between Primary and Metastatic Tumors.
Samdani RT; Wasylishen AR; Halperin DM; Dasari A; Yao JC; Rashid A; Estrella JS
Pancreas; 2019 Apr; 48(4):510-513. PubMed ID: 30946241
[TBL] [Abstract][Full Text] [Related]
45. Heterozygous Men1 mutant mice develop a range of endocrine tumors mimicking multiple endocrine neoplasia type 1.
Bertolino P; Tong WM; Galendo D; Wang ZQ; Zhang CX
Mol Endocrinol; 2003 Sep; 17(9):1880-92. PubMed ID: 12819299
[TBL] [Abstract][Full Text] [Related]
46. Higher risk of aggressive pancreatic neuroendocrine tumors in MEN1 patients with MEN1 mutations affecting the CHES1 interacting MENIN domain.
Bartsch DK; Slater EP; Albers M; Knoop R; Chaloupka B; Lopez CL; Fendrich V; Kann PH; Waldmann J
J Clin Endocrinol Metab; 2014 Nov; 99(11):E2387-91. PubMed ID: 25210877
[TBL] [Abstract][Full Text] [Related]
47. Multiple microvascular alterations in pancreatic islets and neuroendocrine tumors of a Men1 mouse model.
Chu X; Gao X; Jansson L; Quach M; Skogseid B; Barbu A
Am J Pathol; 2013 Jun; 182(6):2355-67. PubMed ID: 23583653
[TBL] [Abstract][Full Text] [Related]
48. Dynamic epigenetic regulation by menin during pancreatic islet tumor formation.
Lin W; Watanabe H; Peng S; Francis JM; Kaplan N; Pedamallu CS; Ramachandran A; Agoston A; Bass AJ; Meyerson M
Mol Cancer Res; 2015 Apr; 13(4):689-98. PubMed ID: 25537453
[TBL] [Abstract][Full Text] [Related]
49. AKT inhibition by triciribine alone or as combination therapy for growth control of gastroenteropancreatic neuroendocrine tumors.
Gloesenkamp CR; Nitzsche B; Ocker M; Di Fazio P; Quint K; Hoffmann B; Scherübl H; Höpfner M
Int J Oncol; 2012 Mar; 40(3):876-88. PubMed ID: 22075556
[TBL] [Abstract][Full Text] [Related]
50. Reduced menin expression impairs rapamycin effects as evidenced by an increase in mTORC2 signaling and cell migration.
Razmara M; Monazzam A; Skogseid B
Cell Commun Signal; 2018 Oct; 16(1):64. PubMed ID: 30285764
[TBL] [Abstract][Full Text] [Related]
51. An inducible knockout mouse to model the cell-autonomous role of PTEN in initiating endometrial, prostate and thyroid neoplasias.
Mirantes C; Eritja N; Dosil MA; Santacana M; Pallares J; Gatius S; Bergadà L; Maiques O; Matias-Guiu X; Dolcet X
Dis Model Mech; 2013 May; 6(3):710-20. PubMed ID: 23471917
[TBL] [Abstract][Full Text] [Related]
52. Deletion of Pten in pancreatic ß-cells protects against deficient ß-cell mass and function in mouse models of type 2 diabetes.
Wang L; Liu Y; Yan Lu S; Nguyen KT; Schroer SA; Suzuki A; Mak TW; Gaisano H; Woo M
Diabetes; 2010 Dec; 59(12):3117-26. PubMed ID: 20852026
[TBL] [Abstract][Full Text] [Related]
53. Inactivation of Pten in osteo-chondroprogenitor cells leads to epiphyseal growth plate abnormalities and skeletal overgrowth.
Ford-Hutchinson AF; Ali Z; Lines SE; Hallgrímsson B; Boyd SK; Jirik FR
J Bone Miner Res; 2007 Aug; 22(8):1245-59. PubMed ID: 17456009
[TBL] [Abstract][Full Text] [Related]
54. Asymptomatic children with multiple endocrine neoplasia type 1 mutations may harbor nonfunctioning pancreatic neuroendocrine tumors.
Newey PJ; Jeyabalan J; Walls GV; Christie PT; Gleeson FV; Gould S; Johnson PR; Phillips RR; Ryan FJ; Shine B; Bowl MR; Thakker RV
J Clin Endocrinol Metab; 2009 Oct; 94(10):3640-6. PubMed ID: 19622622
[TBL] [Abstract][Full Text] [Related]
55. MEN1 Degradation Induced by Neddylation and the CUL4B-DCAF7 Axis Promotes Pancreatic Neuroendocrine Tumor Progression.
Xu J; Ye Z; Zhuo Q; Gao H; Qin Y; Lou X; Zhang W; Wang F; Wang Y; Jing D; Fan G; Zhang Y; Chen X; Chen J; Xu X; Yu X; Ji S
Cancer Res; 2023 Jul; 83(13):2226-2247. PubMed ID: 36939378
[TBL] [Abstract][Full Text] [Related]
56. MEN1 gene mutations in sporadic neuroendocrine tumors of foregut derivation.
Fujii T; Kawai T; Saito K; Hishima T; Hayashi Y; Imura J; Hironaka M; Hosoya Y; Koike M; Fukayama M
Pathol Int; 1999 Nov; 49(11):968-73. PubMed ID: 10594843
[TBL] [Abstract][Full Text] [Related]
57. MEN1 promotes ferroptosis by inhibiting mTOR-SCD1 axis in pancreatic neuroendocrine tumors.
Ye Z; Chen H; Ji S; Hu Y; Lou X; Zhang W; Jing D; Fan G; Zhang Y; Chen X; Zhuo Q; Chen J; Xu X; Yu X; Xu J; Qin Y; Gao H
Acta Biochim Biophys Sin (Shanghai); 2022 Nov; 54(11):1599-1609. PubMed ID: 36604142
[TBL] [Abstract][Full Text] [Related]
58. Synergistic action of Smad4 and Pten in suppressing pancreatic ductal adenocarcinoma formation in mice.
Xu X; Ehdaie B; Ohara N; Yoshino T; Deng CX
Oncogene; 2010 Feb; 29(5):674-86. PubMed ID: 19901970
[TBL] [Abstract][Full Text] [Related]
59. MEN1 deficiency leads to neuroendocrine differentiation of lung cancer and disrupts the DNA damage response.
Qiu H; Jin BM; Wang ZF; Xu B; Zheng QF; Zhang L; Zhu LY; Shi S; Yuan JB; Lin X; Gao SB; Jin GH
Nat Commun; 2020 Feb; 11(1):1009. PubMed ID: 32081882
[TBL] [Abstract][Full Text] [Related]
60. Conditional deletion of the Pten gene in the mouse prostate induces prostatic intraepithelial neoplasms at early ages but a slow progression to prostate tumors.
Kwak MK; Johnson DT; Zhu C; Lee SH; Ye DW; Luong R; Sun Z
PLoS One; 2013; 8(1):e53476. PubMed ID: 23308230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
